Policy Outlook: Understanding the Effects of the U.S. Inflation Reduction Act
10:00 AM - 10:45 AM (EST), Tuesday, February 7, 2023 ・ South Broadway Ballroom
With the passage of the U.S. Inflation Reduction Act in August, biopharma companies must consider how this impacts their portfolio. Will companies adjust their R&D investments? Will investors become more hesitant? This session will cover how to navigate the new law as executives consider the strategic, business development, and legal implications.
Senior Vice President & Head Worldwide Value Access & Payment and Health Economics and Outcomes Research
Bristol Myers Squibb Company